Likewise, expression of SPI1 is severely reduced in human patients with chronic myeloid leukemia due to aberrant promoter methylation in tumor cells (Yang et al., 2012). Here, SPI1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.